Cabot (NYSE:CBT) Posts Earnings Results, Beats Expectations By $0.02 EPS

Posted by Brenda Bartman on Aug 3rd, 2026

Cabot (NYSE:CBT – Get Free Report) released its quarterly earnings results on Monday. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.65 by $0.02, FiscalAI reports. The business had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%. Cabot updated its FY 2026 guidance to 6.150-6.450 EPS.

Cabot Trading Up 2.2%

Shares of Cabot stock traded up $1.98 on Monday, hitting $90.00. 550,866 shares of the company’s stock traded hands, compared to its average volume of 473,501. The firm’s 50-day moving average price is $87.89 and its two-hundred day moving average price is $79.43. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The stock has a market capitalization of $4.65 billion, a PE ratio of 17.01, a price-to-earnings-growth ratio of 11.46 and a beta of 0.83. Cabot has a one year low of $58.33 and a one year high of $94.53.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is currently 35.73%.

Wall Street Analyst Weigh In

CBT has been the topic of a number of research reports. UBS Group upped their target price on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Truist Financial initiated coverage on shares of Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Mizuho lifted their target price on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Cabot presently has a consensus rating of “Hold” and an average target price of $85.80.

View Our Latest Report on CBT

Institutional Investors Weigh In On Cabot

Institutional investors have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio lifted its stake in Cabot by 15.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock valued at $80,000 after buying an additional 160 shares during the period. Janney Montgomery Scott LLC raised its position in shares of Cabot by 2.6% during the fourth quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock worth $417,000 after purchasing an additional 161 shares during the period. Geneos Wealth Management Inc. raised its position in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Global Retirement Partners LLC lifted its holdings in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in shares of Cabot by 709.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock valued at $41,000 after purchasing an additional 468 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.